0001707597-17-000001.txt : 20171214 0001707597-17-000001.hdr.sgml : 20171214 20171213210340 ACCESSION NUMBER: 0001707597-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171214 DATE AS OF CHANGE: 20171213 EFFECTIVENESS DATE: 20171214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Koligo Therapeutics Inc. CENTRAL INDEX KEY: 0001707597 IRS NUMBER: 811717874 STATE OF INCORPORATION: KY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300681 FILM NUMBER: 171255041 BUSINESS ADDRESS: STREET 1: 632 RUSSELL ST CITY: COVINGTON STATE: KY ZIP: 41011 BUSINESS PHONE: 6463317899 MAIL ADDRESS: STREET 1: 632 RUSSELL ST CITY: COVINGTON STATE: KY ZIP: 41011 D 1 primary_doc.xml X0708 D LIVE 0001707597 Koligo Therapeutics Inc. 204 South Floyd St Louisville KY KENTUCKY 40202 6463317899 KENTUCKY None None Corporation true 2016 Matthew B Lehman 204 South Floyd St Louisville KY KENTUCKY 40202 Executive Officer Director David Blanford 204 South Floyd St Louisville KY KENTUCKY 40202 Director Stuart Williams 204 South Floyd St Louisville KY KENTUCKY 40202 Director Balamurugan Appakalai 204 South Floyd St Louisville KY KENTUCKY 40202 Director Michael Hughes 204 South Floyd St Louisville KY KENTUCKY 40202 Director Biotechnology $1 - $1,000,000 06b false 2017-12-01 false true false 0 5000 5000 0 false 6 0 0 1000 true false Koligo Therapeutics Inc. Matthew Lehman Matthew Lehman CEO 2017-12-13